Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24531128)

1.

Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma.

Han X, Li F, Fang Z, Gao Y, Li F, Fang R, Yao S, Sun Y, Li L, Zhang W, Ma H, Xiao Q, Ge G, Fang J, Wang H, Zhang L, Wong KK, Chen H, Hou Y, Ji H.

Nat Commun. 2014;5:3261. doi: 10.1038/ncomms4261.

2.

YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression.

Gao Y, Zhang W, Han X, Li F, Wang X, Wang R, Fang Z, Tong X, Yao S, Li F, Feng Y, Sun Y, Hou Y, Yang Z, Guan K, Chen H, Zhang L, Ji H.

Nat Commun. 2014 Aug 13;5:4629. doi: 10.1038/ncomms5629.

PMID:
25115923
3.

LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response.

Li F, Han X, Li F, Wang R, Wang H, Gao Y, Wang X, Fang Z, Zhang W, Yao S, Tong X, Wang Y, Feng Y, Sun Y, Li Y, Wong KK, Zhai Q, Chen H, Ji H.

Cancer Cell. 2015 May 11;27(5):698-711. doi: 10.1016/j.ccell.2015.04.001. Epub 2015 Apr 30.

PMID:
25936644
4.

Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.

Kim MJ, Shin HC, Shin KC, Ro JY.

Ann Diagn Pathol. 2013 Feb;17(1):85-90. doi: 10.1016/j.anndiagpath.2012.07.006. Epub 2012 Oct 4.

PMID:
23040737
5.

Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.

Sethi S, Geng L, Shidham VB, Archuletta P, Bandyophadhyay S, Feng J, Madan S, Shi D, Tranchida P, Giorgadze T.

Cytojournal. 2012;9:10. doi: 10.4103/1742-6413.94570. Epub 2012 Mar 31.

6.

LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling.

Gao Y, Xiao Q, Ma H, Li L, Liu J, Feng Y, Fang Z, Wu J, Han X, Zhang J, Sun Y, Wu G, Padera R, Chen H, Wong KK, Ge G, Ji H.

Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18892-7. doi: 10.1073/pnas.1004952107. Epub 2010 Oct 18.

8.

Angiogenic switching in the alveolar capillaries in primary lung adenocarcinoma and squamous cell carcinoma.

Morishita C, Jin E, Kikuchi M, Egawa S, Fujiwara M, Ohaki Y, Ghazizadeh M, Takemura T, Kawanami O.

J Nippon Med Sch. 2007 Oct;74(5):344-54.

9.

Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.

Terry J, Leung S, Laskin J, Leslie KO, Gown AM, Ionescu DN.

Am J Surg Pathol. 2010 Dec;34(12):1805-11. doi: 10.1097/PAS.0b013e3181f7dae3.

PMID:
21107086
10.

Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma.

Intaraphet S, Kasatpibal N, Siriaunkgul S, Sogaard M, Patumanond J, Khunamornpong S, Chandacham A, Suprasert P.

Asian Pac J Cancer Prev. 2013;14(9):5355-60.

11.

Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.

Kim YB, Kim GE, Pyo HR, Cho NH, Keum KC, Lee CG, Seong J, Suh CO, Park TK.

Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):822-9.

PMID:
15465199
12.

Significance of EpCAM and TROP2 expression in non-small cell lung cancer.

Pak MG, Shin DH, Lee CH, Lee MK.

World J Surg Oncol. 2012 Apr 6;10:53. doi: 10.1186/1477-7819-10-53.

13.

[Comparison of tumor suppressor gene deletion between squamous cell carcinoma and adenocarcinoma lung cancer in Chinese].

An Q, Liu Y, Huang J.

Zhonghua Zhong Liu Za Zhi. 2001 Nov;23(6):470-2. Chinese.

PMID:
11859712
14.

Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers.

Daraselia N, Wang Y, Budoff A, Lituev A, Potapova O, Vansant G, Monforte J, Mazo I, Ossovskaya VS.

Am J Cancer Res. 2012;2(1):93-103. Epub 2011 Nov 19.

15.

Different impact of IL10 haplotype on prognosis in lung squamous cell carcinoma and adenocarcinoma.

Wang YC, Sung WW, Wang L, Cheng YW, Chen CY, Wu TC, Shieh SH, Lee H.

Anticancer Res. 2013 Jun;33(6):2729-35.

PMID:
23749933
16.

p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.

Nobre AR, Albergaria A, Schmitt F.

Acta Cytol. 2013;57(1):1-8. doi: 10.1159/000345245. Epub 2012 Dec 6. Review.

17.

Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small-cell human lung carcinoma lines.

Söderdahl G, Betsholtz C, Johansson A, Nilsson K, Bergh J.

Int J Cancer. 1988 Apr 15;41(4):636-41.

PMID:
2833454
18.

Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis.

Zang X, Chen M, Zhou Y, Xiao G, Xie Y, Wang X.

Cancer Inform. 2015 May 24;14(Suppl 2):183-91. doi: 10.4137/CIN.S17287. eCollection 2015.

19.
20.

Erythrocyte fatty acids as potential biomarkers in the diagnosis of advanced lung adenocarcinoma, lung squamous cell carcinoma, and small cell lung cancer.

de Castro J, Rodríguez MC, Martínez-Zorzano VS, Sánchez-Rodríguez P, Sánchez-Yagüe J.

Am J Clin Pathol. 2014 Jul;142(1):111-20. doi: 10.1309/AJCP1QUQQLLT8BLI.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk